AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 294: R438-R447, 2008. First published November 21, 2007; doi:10.1152/ajpregu.00590.2007
0363-6119/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/R438    most recent
00590.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Bivol, L. M.
Right arrow Articles by Iversen, B. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bivol, L. M.
Right arrow Articles by Iversen, B. M.

RENAL HEMODYNAMICS AND CARDIORENAL INTEGRATION

Tetradecylthioacetic acid prevents the inflammatory response in two-kidney, one-clip hypertension

Liliana M. Bivol,1,3 Rolf K. Berge,2,3 and Bjarne M. Iversen1,3

1Renal Research Group and 2Lipid Research Group, Institute of Medicine, University of Bergen, and 3Haukeland University Hospital, Bergen, Norway

Submitted 16 August 2007 ; accepted in final form 15 November 2007

ANG II promotes inflammation through nuclear factor-{kappa}B (NF-{kappa}B)-mediated induction of cytokines and reactive oxygen species (ROS). The aim of the present study was to examine the effect of tetradecylthioacetic acid (TTA), a modified fatty acid, on NF-{kappa}B, proinflammatory markers, ROS, and nitric oxide (NO) production in two-kidney, one-clip (2K1C) hypertension. The 2K1C TTA-treated group had lower blood pressure (128 ± 3 mmHg) compared with 2K1C nontreated (178 ± 5 mmHg, P < 0.001). The p50 and p65 subunits of NF-{kappa}B were higher in the clipped kidney (0.44 ± 0.01 and 0.22 ± 0.01, respectively) compared with controls (0.25 ± 0.03 and 0.12 ± 0.02, respectively, P < 0.001). In the 2K1C TTA-treated group, these values were similar to control levels. The same pattern of response was seen in the nonclipped kidney. In 2K1C hypertension, cytokines plasma were higher than in control: TNF-{alpha} was 13.5 ± 2 pg/ml (P < 0.03), IL-1β was 58.8 ± 10 pg/ml (P = 0.003), IL-6 was 210 ± 33 pg/ml (P < 0.001), and monocyte chemoattractant protein-1 was 429 ± 21 pg/ml (P = 0.04). In the 2K1C TTA-treated group, these values were similar to controls, and the same pattern was seen in the clipped kidney. Clipping increased 8-iso-PGF-2{alpha} (P < 0.01) and decreased NO production (P < 0.01 vs. control) in the urine. TTA treatment normalized these values. NO production was also lower in clipped and nonclipped kidney (P < 0.001). After TTA treatment, these values were similar to controls. The results indicate that TTA has a potent anti-inflammatory effect in 2K1C by inhibition of p50/p65 NF-{kappa}B subunit activation, reduction of cytokines production and ROS, and enhanced NO production.

nuclear factor-{kappa}B; cytokines; reactive oxygen species; nitric oxide



Address for reprint requests and other correspondence: L. M. Bivol, Renal Research Group, Institute of Medicine, Haukeland Hospital, N-5021 Bergen, Norway (e-mail: monica.bivol{at}med.uib.no)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.